[Treatment and prevention of conjugation jaundice in newborn infants]. / Lechenie i profilaktika konïugatsionnoi zheltukhi u novorozhdennykh.

Risk factors of conjugation jaundice, developing in full-term newborns are listed. They should be taken into account at first neonatal examination of the infant in order to timely prevent marked hyperbilirubinemia. Treatment for conjugation jaundice should be combined and aim to improve hepatic activity and bilirubin lysis and withdrawal from the body.

[Etiology of toxic erythema in newborn infants and its effects on the health status of young children]. / Etiologiia toksicheskoi éritemy novorozhdennykh i ee vliianie na sostoianie zdorov'ia detei rannego vozrasta.

A total of 68 neonates with toxic erythema (TE) were examined for risk factors of its origin depending on the intensity of the clinical manifestations of erythema. It has been established that sensitizing factors (aggravated allergological anamnesis, food, allergens, late toxicosis of pregnancy) and high content of estrogen hormones in the newborn are implicated in the genesis of the generalized TE pattern. The study of the catamnesis of 84 children of the first three years of life with a history of TE of the newborn revealed that the children appeared highly susceptible to respiratory diseases and showed early formation of the allergic manifestations. It is recommended that neonates with marked TE should be attributed to the second health group and be administered the treatment and prophylactic measures beginning from the stay at the maternity home.